DETECTION AND MONITORING OF SLEEP APNEA CONDITIONS

    公开(公告)号:US20220175310A1

    公开(公告)日:2022-06-09

    申请号:US17116482

    申请日:2020-12-09

    Abstract: A method of detecting sleep apnea includes generating a cardiac signal indicating activity of a heart of a patient. The method further includes determining a short-term average heart rate and a long-term average heart rate. The method further includes determining a start and end of a heart rate cycle based on the short-term average heart rate and the long-term average heart rate. The method further includes determining physiological parameter values occurring during the heart rate cycle. The method further includes determining whether patient has or has not experienced a sleep apnea event based on whether one or more conditions are satisfied by one or more parameter values for one or more heart rate cycles and responsively generating an indication that patient has or has not experienced a sleep apnea event.

    Input switching in a ventricular pacemaker

    公开(公告)号:US11077307B2

    公开(公告)日:2021-08-03

    申请号:US16449517

    申请日:2019-06-24

    Abstract: An intracardiac pacemaker system is configured to produce physiological atrial event signals by a sensing circuit of a ventricular intracardiac pacemaker and select a first atrial event input as the physiological atrial event signals. The ventricular intracardiac pacemaker detects atrial events from the selected first atrial event input, determines if input switching criteria are met, and switches from the first atrial event input to a second atrial event input in response to the input switching criteria being met. The second atrial event input includes broadcast atrial event signals produced by a second implantable medical device and received by the ventricular intracardiac pacemaker.

    POWER MANAGEMENT FOR IMPLANTABLE MEDICAL DEVICE SYSTEMS

    公开(公告)号:US20190111271A1

    公开(公告)日:2019-04-18

    申请号:US15783573

    申请日:2017-10-13

    Abstract: Techniques for minimizing rate of depletion of a non-rechargeable power source, to extend the operational lifetime of an implantable medical device that includes the non-rechargeable power source, by enforcing operational-mode-specific communication protocols whereby inter-device communication between the implantable medical device and another implantable medical device is such that level of power draw from the non-rechargeable power source by the implantable medical device is less than level of power draw from the rechargeable power source by the another implantable medical device for the implantable medical devices to engage in communication with each other.

    USING BIOMARKER INFORMATION FOR HEART FAILURE RISK COMPUTATION
    39.
    发明申请
    USING BIOMARKER INFORMATION FOR HEART FAILURE RISK COMPUTATION 审中-公开
    使用生物标记信息进行心脏衰竭风险计算

    公开(公告)号:US20160206250A1

    公开(公告)日:2016-07-21

    申请号:US14964529

    申请日:2015-12-09

    Abstract: Provided is a method, system and/or apparatus for determining prospective heart failure event risk. Acquired from a device memory are a heart failure patient's current and preceding risk assessment periods. Counting detected data observations in the current risk assessment period for a current risk assessment total amount and counting detected data observations in the preceding risk assessment period for a preceding risk assessment period total amount. Associating the current risk assessment and preceding risk assessment total amounts with a lookup table to acquire prospective risk of heart failure (HF) event for the preceding risk assessment period and the current risk assessment period. Employing weighted sums of the prospective risk of the HF event for the preceding risk assessment period and the current risk assessment period to calculate a weighted prospective risk of the HF event for a patient. Displaying on a graphical user interface the weighted prospective risk of the HF event for the patient.

    Abstract translation: 提供了一种用于确定预期心力衰竭事件风险的方法,系统和/或装置。 从设备记忆获得的是心力衰竭患者当前和之前的风险评估期。 在当前风险评估期内对目前风险评估总量中检测到的数据观察进行计数,并对先前风险评估期总金额的前一风险评估期内检测到的数据观察进行计数。 将当前的风险评估与以前的风险评估总量与查找表相关联,以获得前面的风险评估期和当前风险评估期的心力衰竭(HF)事件的预期风险。 在前面的风险评估期和当前风险评估期间采用HF事件的预期风险的加权总和来计算患者HF事件的加权前瞻性风险。 在图形用户界面上显示患者HF事件的加权前瞻性风险。

Patent Agency Ranking